These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL. Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH Leuk Res; 2011 Mar; 35(3):305-9. PubMed ID: 20869771 [TBL] [Abstract][Full Text] [Related]
4. The synthetic peptide PFWT disrupts AF4-AF9 protein complexes and induces apoptosis in t(4;11) leukemia cells. Srinivasan RS; Nesbit JB; Marrero L; Erfurth F; LaRussa VF; Hemenway CS Leukemia; 2004 Aug; 18(8):1364-72. PubMed ID: 15269783 [TBL] [Abstract][Full Text] [Related]
5. Authors' comments: t(4;11) leukemias display addiction to MLL-AF4 but not to AF4-MLL. Kumar AR; Yao Q; Li Q; Sam TA; Kersey JH Leuk Res; 2011 May; 35(5):697. PubMed ID: 21277021 [No Abstract] [Full Text] [Related]
6. Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia. Sait SN; Claydon MA; Conroy JM; Nowak NJ; Barcos M; Baer MR Cancer Genet Cytogenet; 2007 Sep; 177(2):143-6. PubMed ID: 17854671 [TBL] [Abstract][Full Text] [Related]
8. Simultaneous localization of MLL, AF4 and ENL genes in interphase nuclei by 3D-FISH: MLL translocation revisited. Gué M; Sun JS; Boudier T BMC Cancer; 2006 Jan; 6():20. PubMed ID: 16433901 [TBL] [Abstract][Full Text] [Related]
9. It takes two-to-leukemia: about addictions and requirements. Marschalek R Leuk Res; 2011 Mar; 35(3):424-5. PubMed ID: 21074267 [No Abstract] [Full Text] [Related]
10. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group. Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312 [TBL] [Abstract][Full Text] [Related]
11. The heterodimerization domains of MLL-FYRN and FYRC--are potential target structures in t(4;11) leukemia. Pless B; Oehm C; Knauer S; Stauber RH; Dingermann T; Marschalek R Leukemia; 2011 Apr; 25(4):663-70. PubMed ID: 21233834 [TBL] [Abstract][Full Text] [Related]
12. Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Corral J; Forster A; Thompson S; Lampert F; Kaneko Y; Slater R; Kroes WG; van der Schoot CE; Ludwig WD; Karpas A Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8538-42. PubMed ID: 8378328 [TBL] [Abstract][Full Text] [Related]
13. Identification of complex genomic breakpoint junctions in the t(9;11) MLL-AF9 fusion gene in acute leukemia. Super HG; Strissel PL; Sobulo OM; Burian D; Reshmi SC; Roe B; Zeleznik-Le NJ; Diaz MO; Rowley JD Genes Chromosomes Cancer; 1997 Oct; 20(2):185-95. PubMed ID: 9331569 [TBL] [Abstract][Full Text] [Related]
15. Resistance of t(4;11) (MLL-AF4 fusion gene) leukemias to stress-induced cell death: possible mechanism for extensive extramedullary accumulation of cells and poor prognosis. Kersey JH; Wang D; Oberto M Leukemia; 1998 Oct; 12(10):1561-4. PubMed ID: 9766500 [TBL] [Abstract][Full Text] [Related]
16. Identification of MLL and chimeric MLL gene products involved in 11q23 translocation and possible mechanisms of leukemogenesis by MLL truncation. Joh T; Kagami Y; Yamamoto K; Segawa T; Takizawa J; Takahashi T; Ueda R; Seto M Oncogene; 1996 Nov; 13(9):1945-53. PubMed ID: 8934541 [TBL] [Abstract][Full Text] [Related]
18. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells. Moneypenny CG; Shao J; Song Y; Gallagher EP Carcinogenesis; 2006 Apr; 27(4):874-81. PubMed ID: 16377807 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia. Feng Z; Yao Y; Zhou C; Chen F; Wu F; Wei L; Liu W; Dong S; Redell M; Mo Q; Song Y J Hematol Oncol; 2016 Mar; 9():24. PubMed ID: 26970896 [TBL] [Abstract][Full Text] [Related]
20. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations. Drexler HG; Quentmeier H; MacLeod RA Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]